Nutraceuticals

Berberine

Isoquinoline alkaloid

A rare compound with real human-trial evidence — studied for reducing colorectal adenoma recurrence, alongside a broad mechanistic case from cell and animal research.

Black Seed Oil

Nigella sativa (seed oil)

Thymoquinone appears to work two directions at once — pressuring tumour cells with oxidative stress while supporting normal tissue through the same redox pathway.

Boswellia

Boswellia serrata (resin)

AKBA (3-O-acetyl-11-keto-β-boswellic acid) is the most intensively studied of Boswellia's boswellic acids and underlies many of the mechanisms described below, though whole-extract clinical effects can't be attributed to it alone.

CBD

Cannabis sativa L.

Two evidence tracks run in parallel: laboratory and animal research on tumour biology, and early clinical work on symptom and quality-of-life support during treatment.

CBG

Cannabis sativa L. (minor cannabinoid)

Ask what CBG does to a tumour cell, and the laboratory record answers in several distinct ways — ask what it does in a person, and it falls almost silent.

Curcumin

Curcuma longa (rhizome)

An unusually deep preclinical case across several cancer types, tempered by curcumin's own oral bioavailability problem — the reason enhanced formulations matter so much here.

EGCG

Epigallocatechin gallate — green tea catechin

EGCG's case is unusually broad rather than unusually deep, and both halves are worth taking seriously.

Luteolin

Chrysanthemum morifolium / Perilla frutescens

A broad preclinical evidence base spanning inflammatory, vascular, and growth-signalling pathways, with delivery-system research addressing its limited oral bioavailability.